Recent Quarter Total Invested
$2.66 B
Recent Quarter Institutional Ownership Percentage
108.33%
Total Invested of Last Quarter
$2.58 B
Ownership Percentage of Last Quarter
118.22%
Celldex Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 9.24 M | $314.19 M | 14.46% | 13.94% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 4.88 M | $165.87 M | 100.00% | 7.36% |
| KYNAM CAPITAL MANAGEMENT, LP | 11/14/2024 | 3.46 M | $117.56 M | 2.06% | 5.22% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 3.33 M | $113.25 M | 0.15% | 5.03% |
| BELLEVUE GROUP AG | 11/14/2024 | 3.07 M | $104.40 M | 3.37% | 4.63% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 2.88 M | $97.91 M | -9.21% | 4.34% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 2.72 M | $92.48 M | -11.57% | 4.10% |
| STATE STREET CORP | 11/14/2024 | 2.49 M | $84.47 M | -6.54% | 3.75% |
| WOODLINE PARTNERS LP | 11/14/2024 | 2.34 M | $79.57 M | 208.95% | 3.53% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.84 M | $62.40 M | 110.00% | 2.77% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2024 | 1.73 M | $58.96 M | 100.00% | 2.62% |
| COMMODORE CAPITAL LP | 11/14/2024 | 1.62 M | $55.03 M | 13.61% | 2.44% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 1.57 M | $53.32 M | -19.05% | 2.37% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.54 M | $52.37 M | 0.43% | 2.32% |
| JENNISON ASSOCIATES LLC | 11/08/2024 | 1.32 M | $45.02 M | 32.03% | 2.00% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 1.14 M | $38.70 M | -17.72% | 1.72% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 1.10 M | $37.52 M | -21.10% | 1.67% |
| NOVO HOLDINGS A/S | 10/24/2024 | 963,663 | $32.75 M | 13.37% | 1.45% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2024 | 900,000 | $30.59 M | 100.00% | 1.36% |
| CITADEL ADVISORS LLC | 11/14/2024 | 847,281 | $28.80 M | 163.78% | 1.28% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 825,117 | $28.05 M | -2.42% | 1.24% |
| REDMILE GROUP, LLC | 11/14/2024 | 657,175 | $22.34 M | -8.56% | 0.99% |
| ECOR1 CAPITAL, LLC | 11/14/2024 | 650,000 | $22.09 M | 0.00% | 0.98% |
| EVERSEPT PARTNERS, LP | 11/14/2024 | 564,902 | $19.20 M | -10.76% | 0.85% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 538,856 | $18.32 M | 1.59% | 0.81% |
| 5AM VENTURE MANAGEMENT, LLC | 11/14/2024 | 497,270 | $16.90 M | 0.00% | 0.75% |
| EMERALD ADVISERS, LLC | 10/29/2024 | 456,202 | $15.51 M | 129.91% | 0.69% |
| MORGAN STANLEY | 11/14/2024 | 435,818 | $14.81 M | 165.76% | 0.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2024 | 419,103 | $14.25 M | 35.52% | 0.63% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 415,364 | $14.12 M | -0.15% | 0.63% |
| FISHER ASSET MANAGEMENT, LLC | 11/12/2024 | 374,352 | $12.72 M | 210.55% | 0.56% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 363,635 | $12.36 M | -15.80% | 0.55% |
| CAPTION MANAGEMENT, LLC | 11/14/2024 | 350,000 | $11.90 M | 100.00% | 0.53% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 305,500 | $10.38 M | 100.00% | 0.46% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2024 | 300,000 | $10.20 M | 100.00% | 0.45% |
| MARSHALL WACE, LLP | 11/14/2024 | 276,728 | $9.41 M | -79.92% | 0.42% |
| TSP CAPITAL MANAGEMENT GROUP, LLC | 10/15/2024 | 247,820 | $8.42 M | -0.56% | 0.37% |
| BAKER BROS. ADVISORS LP | 11/14/2024 | 247,644 | $8.42 M | 0.00% | 0.37% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 10/29/2024 | 243,795 | $8.29 M | 92.02% | 0.37% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 218,438 | $7.42 M | -11.60% | 0.33% |
| AXA S.A. | 11/14/2024 | 185,334 | $6.30 M | 30.25% | 0.28% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 181,200 | $6.16 M | -21.27% | 0.27% |
| READYSTATE ASSET MANAGEMENT LP | 11/14/2024 | 179,518 | $6.10 M | 100.00% | 0.27% |
| UBS GROUP AG | 11/14/2024 | 166,597 | $5.66 M | 3.74% | 0.25% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 164,078 | $5.45 M | -13.50% | 0.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 145,000 | $4.93 M | -61.32% | 0.22% |
| TWINBEECH CAPITAL LP | 11/14/2024 | 140,502 | $4.78 M | 279.68% | 0.21% |
| CRESTLINE MANAGEMENT, LP | 11/13/2024 | 137,988 | $4.69 M | 61.67% | 0.21% |
| BARCLAYS PLC | 11/19/2024 | 130,381 | $4.43 M | 140.67% | 0.20% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 125,000 | $4.25 M | -73.71% | 0.19% |
Celldex Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CLDX shares?
During the previous two years, 210 institutional investors and hedge funds held shares of Celldex Therapeutics, Inc.. The most heavily invested institutionals were:
WELLINGTON MANAGEMENT GROUP LLP: 9.24 M
BlackRock Funding, Inc. /DE: 4.88 M
Kynam Capital Management, LP: 3.46 M
EVENTIDE ASSET MANAGEMENT, LLC: 3.33 M
Bellevue Group AG: 3.07 M
PRICE T ROWE ASSOCIATES INC /MD/: 2.88 M
-
What percentage of Celldex Therapeutics, Inc. stock is owned by institutional investors?
108.33% of Celldex Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at CLDX ?
Institutional investors have bought a total of 68.78 M shares in the last 24 months. This purchase volume represents approximately $1.86 B in transactions.